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Abstract
The precise mechanism by which glucocorticoid receptor (GR) regulates the transcription of its target genes is largely
unknown. This is, in part, due to the lack of structural and functional information about GR’s N-terminal activation function
domain, AF1. Like many steroid hormone receptors (SHRs), the GR AF1 exists in an intrinsically disordered (ID) conformation
or an ensemble of conformers that collectively appears to be unstructured. The GR AF1 is known to recruit several
coregulatory proteins, including those from the basal transcriptional machinery, e.g., TATA box binding protein (TBP) that
forms the basis for the multiprotein transcription initiation complex. However, the precise mechanism of this process is
unknown. We have earlier shown that conditional folding of the GR AF1 is the key for its interactions with critical coactivator
proteins. We hypothesize that binding of TBP to AF1 results in the structural rearrangement of the ID AF1 domain such that
its surfaces become easily accessible for interaction with other coactivators. To test this hypothesis, we determined whether
TBP binding-induced structure formation in the GR AF1 facilitates its interaction with steroid receptor coactivator-1 (SRC-1),
a critical coactivator that is important for GR-mediated transcriptional activity. Our data show that stoichiometric binding of
TBP induces significantly higher helical content at the expense of random coil configuration in the GR AF1. Further, we
found that this induced AF1 conformation facilitates its interaction with SRC-1, and subsequent AF1-mediated
transcriptional activity. Our results may provide a potential mechanism through which GR and by large other SHRs may
regulate the expression of the GR-target genes.
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Introduction
Ligand-activated glucocorticoid receptor (GR) regulates tran-
scription of target genes by binding to DNA at specific hormone
response elements and by interacting with other coregulatory
proteins [1], [2], [3], [4], [5]. Like other members of the steroid
hormone receptors (SHRs), the GR possesses a modular structure
characterized by three major functional domains: N-terminal
domain (NTD), DNA binding domain (DBD), and ligand binding
domain (LBD) (Figure 1A). The transactivation activity of SHRs is
mainly controlled by two activation function domains, AF1 and
AF2 located in the NTD and LBD, respectively [6], [7], [8], [9],
[10]. The precise mechanism by which SHRs regulate the
transcription of the target genes is largely unknown. This is, in
part, due to the lack of structural and functional information about
AF1 domain. It has been shown that AF1 is constitutively active
and retains 60–80% of the GR transcriptional activity [11], [12],
[13], [14]. The AF1 is defined by amino acids 77–262 in the
human GR [11], [12], [13], [14]. Due to availability of the LBD
crystal structure [15], the relevant structural and functional
properties of AF2 have been well characterized whereas it is
nebulous in the case of AF1.
In spite of rigorous attempts from several laboratories, we have
not yet been able to determine a three-dimensional folded
structure of the NTD/AF1 of any member of SHR family. One
of the biggest obstacles in knowing the structure of AF1 has been
due to its unstructured or intrinsically disordered (ID) conforma-
tion in solution, which is found in transactivation domains of
several transcription factors (TFs) including SHRs [16], [17], [18],
[19], [20], [21], [22]. The GR AF1 recruits other coregulatory
proteins, including proteins from the basal transcriptional
machinery, e.g. TATA box binding protein (TBP) by creating
binding surfaces for these proteins [21], [23], [24], [25]. Other
studies have also shown that transactivation domains of several
TFs including SHRs undergo a disorder/order transition upon
interaction with proteins from the basal transcriptional machinery
[26], [27], [28], [29]. We have earlier shown that conditional
folding of the GR AF1 is the key for its interactions with its critical
coactivator proteins [25].
It is interesting that the ID GR AF1 directly interacts with the
TBP, the critical protein that forms the basis for the multiprotein
transcription initiation complex. However, the precise mechanism
of this process is unknown. In vitro transcription studies indicated
that the holo-GR acts to stabilize the pre-initiation complex [30],
[31], [32]. One possibility may be that TBP binding-induced
structured conformation in AF1 is involved in creating a platform
for the GR AF1-associated coactivators. In this study we tested
whether TBP binding induces structure formation in the GR AF1
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(SRC-1), a critical coactivator which is important for GR-
mediated transcriptional activity, is facilitated. Our results show
that TBP binding induced structure formation in the GR AF1
facilitates its interaction with SRC-1, and subsequent AF1-
mediated transcriptional activity. Our results provide a potential
mechanism through which GR and other SHRs may regulate the
expression of the GR-target genes, information essential to




The pGRE_SEAP vector (BD Biosciences, Palo Alto, CA)
contains three copies of a GRE consensus sequence in tandem,
fused to a TATA-like promoter (PTAL) upstream from the reporter
gene for secreted alkaline phosphatase (SEAP). GR500 encodes
amino acids 1–500 of the human GR, plus a five-residue
nonspecific extension [32]. TBP was cloned into the pcDNA3.1(+)
expression vector (Invitrogen, Carlsbad, CA) and SRC-1 into
pEYFP-SRC-1 as described [18]. DNA sequencing was performed
on all clones to confirm correct sequences.
Protein Expression and Purification
The GR AF1 domain was constructed from human GR cDNA
digested with BglII and inserted into an expression vector pGEX-
4T-1 (Amersham Pharmacia Biotech) as described [25]. TBPC
encoding 181 C-terminal residues of human TBP was expressed in
pET-21d vector [24], [33]. The expression and purification of AF1
protein is described [25]. TBPC was expressed in Escherichia coli
BL21(DE3), and purified on the NTA column (QIAGEN,
Valencia, CA) using imidazole step-gradient. Final protein purity
of both proteins was greater than 95% as verified by presence of a
major single band on SDS-PAGE (Figure S1).
Surface Plasmon Resonance (SPR) analysis
The kinetics of TBPc binding to GR AF1 was determined by
surface plasmon resonance (SPR) on Biacore X-100 plus (GE
Healthcare). The binding reaction was carried out at room
temperature and in a physiologic buffer (0.01 M HEPES, pH 7.4,
0.15 M NaCl, 50 mM EDTA, 0.05% Tween-20). Purified TBPc
Figure 1. Secondary structural elements predictions of the GR AF1. A) Diagram of human GR protein showing major functional domains. B)
Secondary structural elements predictions of the GR AF1 using HNN method as described [34]. Blue, red, and purple colors indicate helix, b-sheet, and
random coil, respectively. C) PONDR plot for AF1 protein disorder prediction [35]. X axis shows amino acid numbers in the GR AF1 sequences, and Y
axis shows probability score.
doi:10.1371/journal.pone.0021939.g001
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250RU through strong ionic interaction. Fc1 channel was equally
treated but without TBPc as the control. Multi-cycle kinetics
procedure was employed to measure the binding. AF1 at different
concentrations (0.2–6.4 mM) was used as analyte, and sequentially
injected over Fc1 and Fc2 channels to measure its binding to
TBPc. The sensor surface was regenerated by 0.3% SDS after each
cycle of binding. The flow rate was kept constant at 30 ml/min.
Data from 120 seconds of association and 180 seconds of
dissociation were collected. The sensorgrams were normalized
by the subtraction of Fc1 from Fc2, and then fitted for kinetics by
Biacore X-100 evaluation software using 1:1 Langmuir binding
model (A+BRAB). The affinity (KD) was calculated from the
equation KD=k d/ka, where ka is association rate and kd is
dissociation rate.
Circular Dichroism (CD) Spectroscopy
The far-UV CD spectra of the purified recombinant AF1,
TBPC, and AF1:TBPC mixtures were recorded at 22uC on a Jasco
815 spectropolarimeter by using a 0.1-cm quartz cell, with a
bandwidth of 0.5 nm and a scan step of 0.5 nm. The spectra were
recorded at a fixed AF1 protein concentration (4.5 mM) and
varying concentrations of TBPC. All the spectra recorded were
corrected for the contribution of solute concentrations. Each
spectrum is a result of five spectra accumulated, averaged, and
smoothed.
Structural predictions for the GR AF1
Network Protein Sequence Analysis was performed using
(http://npsa-pbil.ibcp.fr) as described [34]. Predictions for the
degree of disordered profile, and Charge/Hydropathy analyses
were performed using PONDR prediction (www.pondr.com), as
described [35], [36], and Fold Index was performed (http://bip.
weizmann.ac.il/fldbin/findex) as described [37]. IUPred analysis
was performed (http://iupred.enzim.hu) as described [38].
Immunoprecipitation Assay
5 ml of antibody for SRC-1, and 50 ml of protein A/G-agarose
beads conjugate were incubated for 4 h at 4uC. HeLa nuclear
extract containing 0.5 mg of total protein, and 10 mg of purified
AF1 and/or TBPC were mixed together and incubated for 2 hr at
4uC in a separate tube, and added to the beads, followed by
incubation for another 2 h at 4uC. The beads were centrifuged,
washed thoroughly, resuspended in SDS loading buffer, and
boiled for 5 min to release bound proteins. The released proteins
were resolved by SDS-PAGE and immunoblotted with a GR AF1
antibody after transfer onto a polyvinylidene difluoride membrane
as described previously [25]. The results are expressed as means 6
the standard error. Levels of significance were evaluated by a two-
tailed paired Student t test, and a P value of ,0.05 was considered
significant.
Cell culture and transient transfection
CV-1 cells (American Type Culture Collection) were grown at
37uC in minimal essential medium with Earle’s salts (Invitrogen)
supplemented with 10% (vol/vol) fetal bovine serum (Atlanta
Biologicals, Norcross, GA). Cells were subcultured every 2 to 3
days. CV-1 cells were plated on a 24-well plate (1000 ml/well) one
day before the transfection and transfected by using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol.
Transfected cells were maintained at 37uCi n5 %C O 2 and 95%
air for the duration of the experiment. Transfection efficiency was
normalized by using immunoblot analysis with specific antibody
against AF1.
Reporter gene assays
We used the SEAP reporter system due to its high signal-to-
noise ratio and quantifiable transcriptional activity without the
need for cell disruption. CV-1 cells were cotransfected as described
above with 0.13 mg of pGRE_SEAP reporter vector; 0.13 mgo f
pECFP-GR500, pcDNA3.1-TBP, and/or pYFP-SRC-1. The total
amount of DNA added was kept fixed by the addition of empty
pECFP vector. Medium (25 ml) was collected 24 h later and tested
for the presence of SEAP (Great EscAPe SEAP detection kit; BD
Biosciences) according to the manufacturer’s protocol. The data
from different experiments were normalized to GR500 activity.
The results are expressed as means 6 the standard error. Levels of
significance were evaluated by a two-tailed paired Student t test
and a P value of ,0.05 was considered significant.
Results
Analyses of ID characteristics of the GR AF1 domain
We performed secondary structural analysis of the GR AF1
domain (amino acids 77–262) using Network Protein Sequence
analysis. It is evident from this analysis that a significantly large
number of amino acid sequences represent a random coil
configuration (Figure 1B). Further calculations reveal that more
than 67% of AF1 sequences contain random coil conformation
with only a small proportion as helix and sheet (data not shown).
Predictor of Naturally Disordered Regions (PONDR) analysis for
ID prediction confirms the ID nature of AF1 (Figure 1C) as
evident from the PONDR Score obtained from three different
methods (more than 0.5). Similar results were obtained using
Prediction of Intrinsically Unstructured Proteins (IUPred) analysis
(Figure 2A). To further confirm these findings, we used FoldIndex
method of disorder prediction, which predicts the probability of a
protein/peptide to fold. A large red area (unfolded) compared to
small green area (folded) suggests that a large fraction of the AF1 is
unfolded (Figure 2B). Uversky et al. [36] have introduced a
method for the analysis to distinguish ordered and disordered
protein conformations based only on net charge and hydropathy.
We applied this method to the GR AF1 sequences. It is evident
from the results that AF1 falls within the ID proteins (Figure 2C).
These results were further confirmed from the PONDR Scores
obtained as a function of cumulative fraction of residues
(Figure 2D) in which the black line plot separates the boundary
of database proteins that possess globular structure. It is evident
from the green dot plot of AF1 that it falls within the range of ID
proteins. Together, data support the notion that AF1 possess
characteristics of an ID protein.
Kinetics analysis of TBPc:GR AF1 binding by surface
plasmon resonance (SPR)
To measure the binding kinetics of AF1 to TBP by SPR, TBP
was immobilized to C1 chip as the ligand through strong ionic
interaction, which was based on the high positive charge of TBPC
at physiological pH (pI=10.3). The GR AF1 was used as an
analyte. Low density of TBPC (200–250RU) was immobilized to
eliminate mass transport limitation and heterogenic ligand for the
kinetics assay. The regeneration was optimized to remove both
TBPC and AF1 after the binding. Fresh TBPC was immobilized for
each cycle; therefore, the activity of ligand was same during the
whole process of kinetics assay. As shown in Figure 3A, AF1
exhibited specific binding to TBPC as indicated by the normal
sensorgram response in the Fc2 assay channel, whereas the control
Binding/Folding of Intrinsically Disordered Domain
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sensorgrams were fitted well using 1:1 binding model (Figure 3B;
as shown by black line overlapped with experimental color lines in
each case). Meanwhile the dissociation was very slow, implying
that there could be an induced conformational change upon the
initial binding that caused the formation of stable complex. In fact,
we have previously shown that AF1 undergoes order/disorder
transition under specific conditions [21], [25].
Since the conformational changes are taking place in AF1, and
we used AF1 as the analyte in our SPR assay, it is difficult to be
detected by this method. On the other hand, in single cycle SPR
kinetic assay, we observed that at lower concentrations, the
binding patterns are similar; however, at higher concentrations,
the response became weaker and showed different kinetic behavior
(data not shown), suggesting that there may be conformational
changes occurring in the AF1 when initial AF1:TBP complex is
formed, which is included in the later binding stages. Overall,
AF1:TBP binding displayed a moderate rate of association and
slow dissociation with calculated affinity (KD) of 0.46 mM, similar
to other SHRs, such as binding of estrogen receptor’s AF1/NTD
to TBP [29]. Comparing the actual SPR response to the
immobilized RU of the ligand, we predicted that there could be
only one binding site in the AF1:TBP interaction, which is based
on sensogram response theory using equation: Rmax=R L?(MWA/
MWL)?Sm, where Rmax is the maximum binding response, RL is
the ligand density, MWA, L is the molecular weight of analyte or
ligand, and Sm is the binding valency; TBP and AF1 have similar
molecular weight at 22 kD. Since experimental Rmax was equal to
RL,S m should be 1. These results should help us further identify
the physical binding sites on AF1 and TBP.
Binding of TBP induces structure in otherwise ID GR AF1
domain
To test the effects of TBP binding on the conformational
changes in AF1, we recorded the far-UV CD spectra of purified
recombinant AF1, TBPC, and a mixture of AF1:TBPC at 1:1 ratio.
As expected, AF1 alone shows characteristics of an ID protein, and
TBPC alone shows that of a globular protein with significant
secondary structural elements in it, whereas the complex shows
much higher secondary structural elements in comparison to both
AF1 and TBPC alone (data not shown). Figure 4A shows the
spectra of AF1:TBPC complex at various ratios ranging from
1:0.25 to 1:2. It is clear from these spectra that with increasing
Figure 2. The GR AF1 domain possesses the characteristics of an ID protein. A) IUPred plot for AF1 protein disorder prediction [38]. Score
above 0.5 are considered to be disordered sequences. B) Fold Index showing the probability of AF1 sequences for the propensity to fold [37]. C)
Cumulative fraction of AF1 residues showing ID PONDR score of AF1 [36]. D) Charge-hydropathy analysis using Uversky plot [35,36]. The plot of the
mean hydrophobicity vs. mean net charge of 54 completely disordered proteins (red), and 105 completely ordered proteins (blue). The solid line
represents the border between ordered and disordered proteins. The cyan square corresponds to AF1.
doi:10.1371/journal.pone.0021939.g002
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structural elements as evident from the increased ellipticity at
around 220 nm wavelength followed by a red shift toward
208 nm. When individual data for AF1 and TBPC (at each
concentration) are added and plotted (theoretical sum), similar
spectra in nature are observed (Figure 4B). When the value of
ellipticity at 220 nm was plotted against the increasing concen-
trations of TBPC, a concentration dependent linear relationship
was obtained (Figure 4C). A comparison of data from the
experimental and theoretical sum suggest that with increasing
concentrations of TBPC, the complex adopts significantly higher
helical content in a concentration dependent manner as evident
from the differences in ellipticity at 220 nm (Figure 4C).
To determine the difference between experimental and
theoretical sums, we plotted the differences in ellipticity at
220 nm between the experimental and theoretical sum against
various concentrations. These results suggest that the helical
content in the complex increases up to a ratio of ,1:1, and
saturates afterword, suggesting that the complex keeps adopting
more and more structure formation until the full complex is
formed (Figure 4D). To determine whether these structural
changes observed in the AF1:TBPC complex are happening in
AF1, TBPC, or both, we subtracted the contribution of TBPC from
each spectrum and plotted them with respect to AF1 alone
(Figure 5A). It is evident from the comparison of the spectra that
AF1 adopts significantly higher helical content when complexed
with TBP (Figure 5A). Sigmoidal curves shown in Figure 5 B&C
represent the absolute changes in the ellipticity at 220 nm and
difference in ellipticity in AF1 at each concentration of TBPC,
respectively. To further determine whether the structural changes
observed in the complex are confined to AF1 or TBPC
conformation is also changed, we plotted the spectra of TBPC
alone (Figure 6A) and after subtracting the contribution of AF1 at
each TBPC concentration from AF1:TBPC complex (Figure 6B).
When comparing the changes in the ellipticity at 220 nm
(Figure 6C), we observed a linear relationship with increasing
concentrations of TBPC (blue line) with no significant deviation in
TBPC when present in the complex (red line), suggesting that
unlike AF1, there were no significant structural changes in TBPC
when complex was formed. Together, these results clearly
demonstrate that binding of TBPC to AF1 results in an induced
structure formation in otherwise ID AF1 domain without any
significant perturbation in TBPC structure.
TBP binding-induced structure formation in the GR AF1
facilitates its interaction with SRC-1
It is known that AF1 interacts with SRC-1 to transactivate
gene(s), and that conditional folding is important for this
Figure 3. Analysis of the binding of the GR AF1 to TBP by SPR. TBP was immobilized to the Fc2 channel of C1 chip as the ligand, the Fc1 was
equally treated but without TBP as the control channel. AF1 was used as the analyte to measure the binding as described in ‘‘Materials and methods’’.
A multi-cycle kinetics assay was run by Biacore X-100 plus. A) Raw sensorgrams of Fc1 and Fc2 to show the specific binding of AF1 to TBP. B) The
adjusted sensorgrams (Fc2-Fc1) were overlaid and fitted for kinetics with 1:1 binding model. The measured sensorgrams are shown in color, and the
fitted ones in black. The experiments were repeated twice.
doi:10.1371/journal.pone.0021939.g003
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tion induced in ID AF1 domain by TBP binding is important for
AF1’s interaction with SRC-1. Using immunoprecipitation assay,
we tested the interaction between the AF1 and SRC-1 from HeLa
nuclear extracts. Separate HeLa nuclear extracts supplemented
with purified AF1 6 TBPC protein were prepared. The extracts
were then incubated with antibody-linked beads specific to SRC-1.
The antibody-linked beads were recovered and washed extensive-
ly, and the bound proteins were released and resolved by SDS-
PAGE. An antiserum to amino acids 150 to 175 of the GR was
then used to identify AF1 on the gels. The results of our
immunoprecipitation experiments are shown in Figure 7. The
blots shown in the Figure 7 are for AF1 (MW,22 kD) retained
after immunoprecipitation as assessed by AF1 antibody. Consis-
tent with previous reports [25], in the case of AF1 alone, we
detected a very weak interaction with SRC-1 (Figure 7; Lanes 1 &
2; Upper Panel) from HeLa nuclear extracts. This interaction was
significantly increased (Figure 7; Lanes 3 & 4; Upper Panel) when
AF1 was bound to TBPC, suggesting that TBP binding-induced
formation in AF1 facilitates its interaction with SRC-1 (Figure 7).
A quantitative analysis of this interaction shows ,8 fold increase in
the bound SRC-1, when AF1 is complexed with TBPC compared
to AF1 alone (Figure 7; Lower Panel). These results suggest that
TBP-induced conformation in AF1 is important for AF1’s
interaction with a critical coactivator.
Effect of TBP and SRC-1 interactions on AF1-driven
transcription
We tested the effects of TBP-induced binding/folding events on
AF1-driven transcription using GR-responsive promoters in
transient transfection-based reporter assays in GR-deficient CV-
1 cells. To test the effects of these coregulators on transcription
driven by the human GR AF1, we cotransfected CV-1 cells with a
GRE-dependent reporter gene and a constant amount of GR500
expression vector alone or with added vectors expressing TBP
and/or SRC-1. The GR500 construct is constitutively active as a
transcription factor, while avoiding the possibility of any
contribution from AF2 [18]. Lacking the LBD, GR500 is
transcriptionally active without steroid and can induce genes
and/or apoptosis in cells to nearly the same extent as steroid-
bound holo-GR [18], [24]. As expected, GR500 alone signifi-
cantly increased reporter activity compared to empty vector alone
(Figure 8), and input of the plasmids expressing TBP or SRC-1
gene, enhanced the GR500 induction of the GRE-SEAP reporter
by ,2–3 fold (Figure 8). When cells were co-transfected with
GR500, TBP, and SRC-1 together, the reporter activity was
Figure 4. Secondary structural changes in the AF1:TBPC complex. A) Far-UV CD spectra of the GR AF1:TBPC complex (experimental) at a
constant AF1 and varying concentrations of TBPC (as indicated). B) Far-UV CD spectra of the GR AF1+TBPC (theoretical sum) at a constant AF1 and
varying concentrations of TBPC (as indicated). C) A comparison of changes in the ellipticity at 220 nm for experimental and theoretical sums with
respect to AF1:TBP ratio. D) TBP-induced conformational transition of AF1 as measured in terms of changes in the ellipticity at 220 nm, and plotted
against AF1:TBPC ratio.
doi:10.1371/journal.pone.0021939.g004
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the enhancement of GR-induced transcription by TBP or SRC-1
is achieved through the AF1 region and that TBP binding plays an
important role in it by inducing more helical structure in the
otherwise ID AF1 region, confirming that TBP-induced structure
formation in ID AF1 region aids in facilitating protein-protein
interactions between AF1 and coactivators, which subsequently
helps drive GRE-mediated AF1 transcriptional activity.
Discussion
The GR mediates most of the biological effects of glucocorti-
coids at the level of gene regulation. To regulate the expression of
target genes, the GR interacts with several coregulatory proteins
including coactivators and corepressors [3]. In recent years, based
on the kinetic behavior of the SHR in cells, it has been concluded
that the SHRs function very dynamically such that it rapidly and
reversibly interacts with its coregulatory proteins, and chromatin
and DNA [39], [40]. Requirement of various constellations of
coregulatory proteins to regulate GR target genes suggests that the
kinetics of these interactions must be variable, depending upon the
local concentration and/or binding affinities of these coregulators
[3], [41], [42], [43], [44], [45], [46], [47]. Thus, the overall
picture is one of a complex, dynamic network controlled by the
GR as it interacts reversibly with a variety of other coregulatory
proteins. Since many of these cell-specific interactions between the
GR and other coregulatory proteins take place through AF1
domain, it is logical to build upon the idea that ID nature of AF1
may be a dominant factor in regulating these events. Of course, for
full transcriptional activity, AF1 and AF2 must work synergistically
through cross communication, and this is where the flexible
structural characteristics of AF1 may play a major role by
facilitating protein:protein interactions.
There are reports showing the evidence for a two-step binding
model in which the ID activation domain of c-Myc and estrogen
receptor bind rapidly to TBP due to polar interactions and
subsequently folds to an ordered conformation [26], [29]. Similar
mechanisms have been proposed for the GR as well [21], [24].
TBP has a central role in the basal transcription machinery, and it
is known to bind to several TFs, suggesting that the multiprotein
complexes involving basal transcription machinery proteins and
TF may represent a mechanism through recruitment of TBP to
the TATA box. It is generally believed that activation domains of
many TFs work through an induced binding/folding mechanism,
i.e., they may not be structured until they have recruited and
bound their proper binding partners. In this study we show that
complex formation between the GR AF1 and TBP is accompanied
by a change in protein conformation. An approximate dissociation
constant in the mM range for the interaction between AF1and
TBP was obtained. However, we were not able to make a
Figure 5. Secondary structural changes in AF1 when complexed with TBPC.A ) Far-UV CD spectra showing AF1 after subtracting the
contribution of TBPC in each case. B) A plot ellipticity at 220 nm of AF1:TBPC - TBPC with respect to AF1:TBPC ratio. C) A plot of difference in the
ellipticity at 220 nm of AF1:TBPC - TBPC with respect to AF1:TBPC ratio.
doi:10.1371/journal.pone.0021939.g005
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limitations. A slower dissociation suggests that once the complex is
formed, AF1 must have undergone structural rearrangement such
that AF1 has now adopted a more stable folded conformation.
This is consistent with our findings of increased helical contents in
AF1 when complexed with TBP.
Thus, the emerging picture is that ID transactivation regions
become folded in concert with target factor interaction, and TBP
seems to be a major coregulatory binding partner protein in this
process. The question, therefore, arise whether there could be a
unified mechanism of TBP binding/folding events on the action of
ID activation domains of TFs. We have earlier shown that TBP
interacts with the GR AF1 in cells [24]. We have also shown that
conditional folding of AF1 is critical for its interaction with SRC-1
[18]. Our present studies certainly support the idea. However, the
clear picture will emerge only when the 3-D structures of these
complexes are available. Unlike AF2, no single interaction motif
has been identified for AF1 coregulatory proteins, and it appears
that ID conformation of AF1 helps in promoting molecular
recognition by providing surfaces capable of binding specific target
molecules [17], [19], [26], [27], [28], [29], [48], [49], [50], [51],
[52], [53], [54], [55], [56]. These AF1 surfaces can be achieved
through AF1’s interaction with specific target molecules, and our
data support that TBP may be one such target molecule, since,
unlike several other coregulatory proteins including SRC-1 (which
bind to both AF1 and AF2 regions), TBP binds and regulates GR
activity mainly through AF1 domain [24], [57]. We propose that
the ID nature of the GR AF1 allows it to rapidly ‘‘sample’’ its
environment until coregulatory proteins of appropriate concen-
tration and affinity are found [5].
Our results show that TBP binding induces secondary/tertiary
structure formation in the GR AF1. This TBP binding-induced
folding of the GR AF1 is quite striking in the sense that TBP is the
major component of basal transcription machinery, and a cross
communication of the receptor with the basal transcription
machinery is an essential requirement of regulation of GR target
genes. Our identification of SRC-1, a critical coactivator of GR
activity is a testimony of this fact. We have earlier reported that the
GR AF1-TBP interaction occurs under in vivo conditions, and
amino acid residues 187–242 of the human GR AF1 and amino
acid residues 159–339 of human TBP are critical for this
interaction [24]. It is also interesting to note that unlike AF2,
activation domain-2 (AD2) and possibly AD1 regions of SRC-1
are involved in its interaction with AF1 [58]. SHRs function in an
extremely dynamic situation such that they have the capacity to
rapidly form and reform multiprotein complexes involving
coactivators/corepressors and/or proteins from the fundamental
initiation complex. Thus, TBP binding-induced AF1 conformation
may provide platform(s) for inclusion and/or exclusion of specific
coregulators, which may dictate the final outcome responsible for
the regulation of target genes. These effects of course may be cell-
and promoter- specific.
Figure 6. Secondary structural analyses of TBPC.A ) Far-UV CD spectra of the TBPC at various concentrations. B) Far-UV CD spectra showing
TBPC after subtracting the contribution of AF1 in each case. C) A comparison of changes in the ellipticity at 220 nm for TBPC alone and AF1:TBPC –
AF1 at various concentrations of TBPC.
doi:10.1371/journal.pone.0021939.g006
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e21939It is a well accepted fact that generally, though perhaps not
universally [49], [59] under physiological conditions proteins must
have specific structure to carry out their proper functions. In the
context of the GR AF1, it could be hypothesized that the GR AF1
domain may be structured in vivo, at least when directly involved in
transcriptional activation. Our studies support this notion, that
when carrying out its transcription-regulating function, AF1 shifts
to more structured conformers through specific protein:protein
interaction. Conformational uniqueness of most proteins deter-
mines their biological function, and we propose that the ID nature
of the GR AF1 can explain much about the GR’s observed
dynamic behaviors in cells. The ID AF1 region can be thought of
as a large collection of rapidly inter-convertible conformers, which
can select among available coregulatory proteins to form the basis
for building large transcription-regulating complexes on specific
promoters. Such complexes can dissociate and re-associate with
differing composition.
Our results provide a potential mechanism through which GR
AF1 may regulate the expression of the GR-target genes,
information essential to understand how specific signals are passed
from the receptor to target genes. Because TBP is known to bind
to several transcription factors including SHRs through their ID
activation domain, our results from this study may provide a
mechanism through which ID activation domains form assembly
of critical coregulatory proteins and subsequent transcriptional
activity. Of course, these effects can further be influenced by other
factors such inter-domain interactions, and small molecule ligands
and other protein:protein interactions.
Supporting Information
Figure S1 Coomassie-stained SDS-PAGE gel showing
purified recombinant AF1 and TBPC proteins. AF1
consists of amino acid residues 77–262 of the human GR, and
TBPC represents amino acid residues 159–339 of the human TBP.
MW=Molecular Weight Markers. The numbers on the left show
the size of MW markers.
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